Daratumumab with dose-adjusted EPOCH is feasible in newly diagnosed plasmablastic lymphoma: AIDS Malignancy Consortium 105 Meeting Abstract
| Authors: | Noy, A.; Barta, S. K.; Kwon, D.; Baiocchi, R.; Ramos, J. C.; Rubinstein, P.; Chadburn, A.; Ambinder, R. F. |
| Abstract Title: | Daratumumab with dose-adjusted EPOCH is feasible in newly diagnosed plasmablastic lymphoma: AIDS Malignancy Consortium 105 |
| Meeting Title: | 66th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 144 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Dec 7-10 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-11-05 |
| Start Page: | 870 |
| End Page: | 871 |
| Language: | English |
| ACCESSION: | WOS:001412804100014 |
| DOI: | 10.1182/blood-2024-211388 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
